References
- Borak J, Sidell RF. (1992). Agents of chemical warfare: sulfur mustard. Ann Emerg Med 21:303–308.
- Fox M, Scott D. (1980). The genetic toxicology of nitrogen and sulphur mustard. Mutat Res 75:131–138.
- Ghazanfari T, Faghihzadeh S, Aragizadeh H, Soroush MR, Yaraee R, Hassan ZM, et al. (2009).Sardasht-Iran cohort study of Chemical warfare victims: Design and Methods, Arch Iranian Med 12 (1): 5–14.
- Hamzapour SH, Hassan ZM. (1998). Studies on the immunostatus of B cell CD45/CD19, CD19/CD25 in the people exposed to sulfur mustard. PhD dissertation, University of Shahid Beheshiti.
- Hassan ZM, Ebtekar M. (2002). Immunological consequences of sulfur mustard. Immunological Letters 83:151–152.
- Hassan ZM, Ebtekar M, Ghanei M, Taghikhani M, Noori Daloi MR, Ghazanfari T. (2006). Immunobiological consequences of sulfur mustard contamination. Iran J Allergy Asthma Immunol 5:101–108.
- Lawley PD, Brookes P. (1965). Molecular mechanism of the cytotoxic action of difunctional alkylating agents and of resistance to this action. Nature 206:480–483.
- Mahmoudi M, Hefazi M, Rastin M, Balali-Mood M. (2005). Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans. Int. Immunopharmacol 5:1479–1485.
- Momeni AZ, Enshaeih S, Meghadadi M, Amindjavaheri M. (1992). Skin manifestations of mustard gas: A clinical study 535 patients exposed to mustard gas. Arch Dermat 128:775–780.
- Papirmeister B, Foster JA, Robinson IS, Ford DR. (1991). Medical defense against mustard gas. Boca Raton, FL: CRC Press.
- Pedersen-Bjergaard J, Larsen SO. (1982). Incidence of acute non-lymphocytic leukemia, preleukemia and acute myelo-proliferative syndrome up to 10 years after treatment of Hodgkin’s disease. NEJM 307:965–971.
- Shaker M, Hassan ZM. (1998). Studies on the immunostatus of T cell in the people exposed to sulfur mustard. PhD dissertation, University of Shahid, Beheshiti.
- Shakil FA, Kuramoto A, Yamakido M, Nishimoto Y, Kamada N. (1993). Cytogenetic abnormalities of hematopoetic tissue in retired workers of Ohkunojima poison gas factory. Hiroshima J Med Sci 42:159–165.
- Smith KJ, Hurst CG, Moeller RB, Skelton HG, Sidell FR. (1991). Sulfur mustard: its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanisms of action, its long-term health effects, and new developments for protection and therapy. J Am Acad Dermatol 32:765–766.
- Somani SM, Babu SR. (1995). Therapeutic review: toxicodynamics of sulfur mustard. Int Clin Pharmacol Ther Toxicol 27:419–435.
- Sohrabpour (Sic) H. In: A. Heyndricks, Editor, Proceedings of the 1st World Congress on Biological and Chemical Warfare, Toxicological Evaluation, Ghent Univ. Press, Belgium (1984), pp. 291–297.